Status:
COMPLETED
Validation of the French Adaptation of the MSWDQ-23 Questionnaire
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Brief Summary
MS is an autoimmune disease of the central nervous system that affects more than 120,000 people in France. The average age of onset of the disease is between 25 and 35 years. Given the wide range of a...
Eligibility Criteria
Inclusion
- Age between 18 and 65 years old.
- Native French speaker.
- A diagnosis of Clinically Isolated Syndrome or MS defined according to the 2017 McDonald criteria.
- Be affiliated with the social security system.
- Agree to participate in the study.
Exclusion
- Opposition to the use of the data
Key Trial Info
Start Date :
May 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT04860791
Start Date
May 10 2021
End Date
May 31 2023
Last Update
February 5 2024
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Besancon University Hospital
Besançon, France, 25030
2
Bordeaux university hospital
Bordeaux, France, 33404
3
Caen university hospital
Caen, France, 14033
4
Clermont Ferrand university hospital
Clermont-Ferrand, France, 63003